GovChime
Notice ID: c0fa055913f647c4b3262722fd66122fSpecial NoticeArchived

Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder

Archived on September 30, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EDT
Posted
September 8, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Place of performance
Baltimore, Maryland
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
NOI-PCA-NIDA-09054
Notice ID
c0fa055913f647c4b3262722fd66122f

Description

Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work. 

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (2)

  • NOI-PCA-NIDA-09054.pdf

    186 KBAdded in Special Notice version 3Posted
    Download
  • SOW PCA-NIDA-09054.pdf

    143 KBAdded in Special Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Special NoticeArchivedCurrent

    Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder

    Notice c0fa055913f647c4b3262722fd66122f on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.
68%
Market Research12/04/2026
59%
Market Research11/09/2026
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST.
59%
Solicitation11/04/2026
The South Texas Veterans Health Care System requires contractor services to perform testing and certification of sterile compounding facilities, including primary and secondary engineering controls as described in the attached Performance Work Statement (PWS), at the Audie L. Murphy Memorial VA Hospital Pharmacy Service. All work shall be performed in accordance with applicable standards and the related testing described in the attached PWS. The contractor shall provide all labor, equipment, and documentation needed to fulfill the requirements outlined in the PWS.
59%
Combined Synopsis11/17/2026
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces.
59%
Pre-Solicitation11/02/2026

Additional Details

Solicitation Number

NOI-PCA-NIDA-09054

Archive Date

Sep 30, 2026

Office Address

Bethesda, MD, 20892, US